The Afinion HbA1c assay represents a significant advancement in point-of-care diagnostics, delivering rapid and reliable results for glycated hemoglobin testing directly at the patient’s side. This innovative approach streamlines the process of diabetes diagnosis and monitoring, providing healthcare professionals with immediate insights to enhance patient care. Built upon years of dedicated product development, the Afinion HbA1c test is engineered for simplicity and ease of use, removing complexity from the testing procedure.
Unwavering Confidence in Diagnostic Testing
For over 14 years, the Afinion HbA1c test has maintained both IFCC and NGSP certifications, underscoring its commitment to quality and accuracy. Through continuous refinement, the Afinion HbA1c assay consistently demonstrates exceptional analytical performance, frequently surpassing other point-of-care HbA1c instruments in comparative studies. This long-standing certification and proven performance provide clinicians with confidence in the results, crucial for effective diabetes management.
Achieving Laboratory-Level Precision at the Point of Care
Afinion analyzers are designed to produce highly accurate results, mirroring the precision typically found in laboratory settings. External Quality Assurance (EQA) data consistently demonstrates that the analytical performance of the Afinion 2 Analyzer meets or exceeds the standards of many laboratory-based HbA1c measurement methods. This level of accuracy ensures reliable diagnostic information directly within the clinic or physician’s office, facilitating timely and informed clinical decisions.
A Reliable Tool for Diabetes and Prediabetes Diagnosis
Notably, the Afinion HbA1c assay holds the distinction of being the first point-of-care HbA1c test cleared by the US FDA not only for monitoring diabetes but also as a valuable aid in the diagnosis of both diabetes and prediabetes. This FDA clearance expands the utility of point-of-care HbA1c testing, enabling clinicians to use the Afinion assay as a frontline diagnostic tool, directly contributing to earlier and more effective identification of individuals with diabetes and prediabetes.
Enhancing Clinic Efficiency and Patient Throughput
Implementing point-of-care HbA1c testing in the physician’s office significantly optimizes workflow and boosts clinic productivity. Studies have shown that on-site testing reduces the necessity for multiple patient visits, minimizes the need for venous blood draws, and decreases administrative burdens associated with laboratory orders and result reporting. By streamlining these processes, clinics can free up valuable time and resources, allowing healthcare providers to focus more on direct patient care and expand their capacity to serve more patients efficiently.
Facilitating Immediate and Impactful Patient Consultations
The availability of point-of-care HbA1c test results during patient consultations creates opportunities for immediate and impactful “coachable moments.” When results are readily available, healthcare professionals can engage patients in real-time discussions about their health status, fostering greater patient understanding and motivation. Research indicates that receiving test results during a consultation significantly enhances patient engagement and strengthens their commitment to actively participate in their diabetes care plan.
